Synonyms: α-Dihydrotetrabenazine|α-DTBZ


CAS
85081-18-1
Formulation
A solid
Purity
≥98%
MW
319,4385
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An inhibitor of VMAT2 (Ki = 3.96 nM) and an active metabolite of tetrabenazine and valbenazine; selective for VMAT2 over a panel of 80 receptors at 10 µM; decreases dopamine, 5-HT, and norepinephrine levels and increases DOPAC, HVA, and 5-HIAA levels in the mouse medial prefrontal cortex at 10 mg/kg; induces ptosis and increases serum prolactin levels in rats at 10 mg/kg; inhibits PCP- and amphetamine-induced hyperactivity in mice at 10 mg/kg
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).